InvestorsHub Logo
Followers 125
Posts 21098
Boards Moderated 0
Alias Born 06/13/2011

Re: Number sleven post# 362372

Wednesday, 12/08/2021 2:15:18 PM

Wednesday, December 08, 2021 2:15:18 PM

Post# of 428944
N7. along the lines of near term catalysts
This, very recent interview , from an interventional Cardiologist at a center that does around 2,000 PCI's ( opening occluded coronary arteries ) per yr .....SWAV

Has the pass-through payment helped with IVL use at your lab?
One of the biggest initial factors was the cost of the therapy.
Now, with the added code, we are seeing more and more usage
of IVL in multiple cases. In the beginning, when IVL first came out, I created a proto- col as to when IVL could be pulled by our staff.
But now, anyone can utilize IVL if the lesion failed a noncompliant balloon.



So this wider use due to the recent Medicare pass thru approval .....should show up in their next earnings report .

With AMRN ...everyone will be focusing on the remaining cash on hand in their next earnings report .
KM did the right thing ...slashed US sales force and Ad spend. Something JT should have done long ago .
However we need to make it thru to the Spring / post Covid surge ...before we see any improvement in earnings IMHO .
Until then its preserve cash on hand

Kiwi

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News